Identify fetal cardiac dysfunction
Abnormal ductus venosus waveforms – especially a‑wave reversal – indicate elevated venous pressure and impaired cardiac function, often seen in growth restriction, anaemia, or heart defects.
The ductus venosus is a unique fetal vessel that shunts oxygenated blood from the umbilical vein directly to the inferior vena cava, bypassing the fetal liver. Doppler assessment of the ductus venosus provides critical information about fetal cardiac function, venous pressure, and adaptation to hypoxia. It is a sensitive marker of fetal compromise – particularly in growth restriction (IUGR), congenital heart defects, and chromosomal abnormalities.
Ductus venosus Doppler is typically performed in the second and third trimesters, often as part of a comprehensive fetal assessment in high‑risk pregnancies. The waveform consists of three phases: ventricular systole (S‑wave), early diastole (D‑wave), and atrial contraction (a‑wave). The a‑wave is of particular interest – its absence or reversal indicates elevated cardiac filling pressures and is a late sign of fetal deterioration.
At Amytri, our ductus venosus Doppler examinations are performed by a consultant radiologist with advanced training in fetal medicine. We use high‑resolution ultrasound to obtain clear waveforms, measure velocity indices, and detect any reversal of the a‑wave. Our reports are integrated with other Dopplers (umbilical artery, MCA) and biophysical profile to guide decisions about delivery timing, fetal therapy, or further evaluation.
The ductus venosus waveform is a sensitive indicator of fetal wellbeing – changes in the a‑wave often precede other signs of deterioration, allowing timely intervention.
Abnormal ductus venosus waveforms – especially a‑wave reversal – indicate elevated venous pressure and impaired cardiac function, often seen in growth restriction, anaemia, or heart defects.
In IUGR, ductus venosus Doppler is a key parameter in the staging of fetal deterioration. The appearance of a‑wave reversal is a late sign that often prompts delivery to prevent acidemia and adverse neonatal outcomes.
Serial ductus venosus monitoring in high‑risk pregnancies allows for timely intervention – reducing the risk of fetal acidosis, hypoxic injury, and long‑term neurodevelopmental impairment.
We obtain a high‑quality waveform from the ductus venosus and evaluate the indices that reflect cardiac function and filling pressures.
We evaluate the atrial contraction (a‑wave) phase. A normal a‑wave is forward (above the baseline). An absent or reversed a‑wave indicates elevated right ventricular pressure and is a marker of cardiac dysfunction.
PIV = (S‑a)/D (where S is peak systolic, a is the a‑wave, and D is the D‑wave). An elevated PIV indicates increased venous pressure and is associated with adverse outcomes.
We measure peak velocities during ventricular systole (S) and early diastole (D). Reductions in velocity can indicate reduced venous return or cardiac dysfunction.
We assess the overall contour of the waveform – a blunted or abnormal shape may indicate cardiac compromise, even before a‑wave reversal.
We compare our findings to reference ranges for gestational age, recognizing that ductus venosus indices change with fetal development.
We combine ductus venosus Doppler with umbilical artery Doppler, MCA Doppler, amniotic fluid assessment, and biophysical profile to stage fetal deterioration and guide delivery timing.
Your obstetrician refers you for ductus venosus Doppler – often in the context of fetal growth restriction, suspected cardiac anomaly, or abnormal umbilical artery Doppler.
We locate the ductus venosus in a sagittal section of the fetal abdomen, using colour Doppler. We obtain a spectral waveform with the sample volume placed just proximal to the inlet of the inferior vena cava.
We assess the a‑wave (forward, absent, or reversed), calculate PIV, and measure velocities. A normal waveform with a forward a‑wave is reassuring; a‑wave reversal or elevated PIV indicates cardiac dysfunction.
We provide a detailed Doppler report and discuss the findings with you and your obstetrician. Recommendations may include serial monitoring, fetal echocardiography, or planning for early delivery.
It is typically performed in high‑risk pregnancies, particularly when there is concern about fetal growth, cardiac function, or chromosomal anomalies.
In IUGR, ductus venosus Doppler is a key staging tool – a‑wave reversal is a late sign that often triggers delivery.
Ductus venosus Doppler can assess cardiac function and help determine the severity of heart disease.
Abnormal ductus venosus waveforms are associated with chromosomal conditions – often as part of first‑trimester screening.
When umbilical artery Doppler shows absent or reversed end‑diastolic flow, ductus venosus helps assess the severity of fetal compromise.
Ductus venosus Doppler can detect elevated venous pressure in conditions like fetal anaemia or immune hydrops.
In the first trimester (11‑14 weeks), ductus venosus Doppler is sometimes included in combined screening for trisomy 21 and other chromosomal anomalies.
Ductus venosus Doppler requires technical skill to obtain reliable waveforms and clinical judgment to interpret their significance. Our consultant radiologist has extensive experience in fetal medicine, ensuring accurate assessment of the ductus venosus and integration with other clinical parameters to guide management.
Ductus venosus Doppler is a nuanced test – having your partner with you provides support and shared understanding.
We encourage partners to attend. We explain the waveform and its significance, and answer any questions. If the results are abnormal, we discuss them sensitively and provide a clear plan for management – whether it's closer monitoring, fetal echocardiography, or delivery planning.
It is a specialised ultrasound that measures blood flow in the ductus venosus – a fetal vein that shunts oxygenated blood to the heart. It provides information about fetal cardiac function and venous pressure.
Yes. It uses standard diagnostic ultrasound with no known harmful effects. The thermal index is kept within safe limits, and it is widely used in fetal medicine.
An absent or reversed a‑wave suggests elevated cardiac filling pressures, which can indicate fetal hypoxia, cardiac dysfunction, or acidemia. It is a late sign of fetal deterioration and often guides delivery timing.
It can be performed in the first trimester (as part of aneuploidy screening) or later in pregnancy, especially in the context of fetal growth restriction, congenital heart disease, or abnormal umbilical artery Doppler.
Yes, typically a referral from your obstetrician is required, especially if you have a high‑risk condition. We will work closely with your care team to provide coordinated management.
We will discuss the findings with you and your obstetrician. Depending on the context, recommendations may include fetal echocardiography, closer monitoring, and, if a‑wave reversal is present in IUGR, planning for early delivery to prevent fetal acidosis.
From your baby's very first heartbeat to your family's lifelong health — we're here with precision, expertise and care. Reserve your appointment in under a minute.